Anifrolumab in systemic lupus erythematosus: real-world evidence from a Spanish multicentre cohort of 206 patients and literature review.

Calvo-Río V, Secada-Gómez C, Martín-Gutiérrez A, Retuerto-Guerrero M, Font J, Casafont-Solé I, Mayo-Juanatey A, Alegre Sancho JJ, Freites D, Hormigos C, Garrido Puñal N, González Arribas G, Miguélez Sanchez JR, García-Valle A, Ibañez M, Lozano Morillo F, García Manzanares Á, Sandoval-Moreno S, Cortes-Hernandez J, Palma Sanchez D, Lojo L, Cervantes Pérez EC, Collado P, Arciniega Larios C, Sala Icardo L, Labrador-Sánchez E, Peralta-Ginés C, Urionagüena Onaindia I, Plaza-Aulestia N, Medina Malone M, Gómez de Salazar JR, Corteguera M, Cebrián-Méndez L, Antón Pages FA, Lamua Riazuelo JR, Fábregas Canales MD, Alados Hernández MJ, Garijo Bufort M, Pàmies A, Sarabia de Ardanaz L, Aguirre-Del-Pino R, Cabezas Lefler JÁ, Seijas-Lopez Á, Carrasco Cubero MDC, López-Cerón Cofiño A, Ortiz-Santamaria V, Laiño Piñeiro M, Ordás Calvo C, Arconada Lopez C, Urruticoechea-Arana A, Garcia Magallon B, Acosta Alfaro AV, Leal Rodriguez S, Salido Olivares M, Lavilla Villar P, Brandy-García AM, Ros Vilamajo I, García Martos Á, Magallares Lopez BP, Sada Urmeneta G, Córdoba Martín C, Riera E, Bejerano C, Castañeda S, Blanco R

Open source

DOI
10.1136/rmdopen-2025-006549
Published
2026 Mar 19
Container
RMD open
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/rmdopen-2025-006549,
  title = {Anifrolumab in systemic lupus erythematosus: real-world evidence from a Spanish multicentre cohort of 206 patients and literature review.},
  author = {Calvo-Río V and Secada-Gómez C and Martín-Gutiérrez A and Retuerto-Guerrero M and Font J and Casafont-Solé I and Mayo-Juanatey A and Alegre Sancho JJ and Freites D and Hormigos C and Garrido Puñal N and González Arribas G and Miguélez Sanchez JR and García-Valle A and Ibañez M and Lozano Morillo F and García Manzanares Á and Sandoval-Moreno S and Cortes-Hernandez J and Palma Sanchez D and Lojo L and Cervantes Pérez EC and Collado P and Arciniega Larios C and Sala Icardo L and Labrador-Sánchez E and Peralta-Ginés C and Urionagüena Onaindia I and Plaza-Aulestia N and Medina Malone M and Gómez de Salazar JR and Corteguera M and Cebrián-Méndez L and Antón Pages FA and Lamua Riazuelo JR and Fábregas Canales MD and Alados Hernández MJ and Garijo Bufort M and Pàmies A and Sarabia de Ardanaz L and Aguirre-Del-Pino R and Cabezas Lefler JÁ and Seijas-Lopez Á and Carrasco Cubero MDC and López-Cerón Cofiño A and Ortiz-Santamaria V and Laiño Piñeiro M and Ordás Calvo C and Arconada Lopez C and Urruticoechea-Arana A and Garcia Magallon B and Acosta Alfaro AV and Leal Rodriguez S and Salido Olivares M and Lavilla Villar P and Brandy-García AM and Ros Vilamajo I and García Martos Á and Magallares Lopez BP and Sada Urmeneta G and Córdoba Martín C and Riera E and Bejerano C and Castañeda S and Blanco R},
  year = {2026},
  journal = {RMD open},
  doi = {10.1136/rmdopen-2025-006549},
  url = {https://doi.org/10.1136/rmdopen-2025-006549}
}

RIS

TY  - JOUR
TI  - Anifrolumab in systemic lupus erythematosus: real-world evidence from a Spanish multicentre cohort of 206 patients and literature review.
AU  - Calvo-Río V
AU  - Secada-Gómez C
AU  - Martín-Gutiérrez A
AU  - Retuerto-Guerrero M
AU  - Font J
AU  - Casafont-Solé I
AU  - Mayo-Juanatey A
AU  - Alegre Sancho JJ
AU  - Freites D
AU  - Hormigos C
AU  - Garrido Puñal N
AU  - González Arribas G
AU  - Miguélez Sanchez JR
AU  - García-Valle A
AU  - Ibañez M
AU  - Lozano Morillo F
AU  - García Manzanares Á
AU  - Sandoval-Moreno S
AU  - Cortes-Hernandez J
AU  - Palma Sanchez D
AU  - Lojo L
AU  - Cervantes Pérez EC
AU  - Collado P
AU  - Arciniega Larios C
AU  - Sala Icardo L
AU  - Labrador-Sánchez E
AU  - Peralta-Ginés C
AU  - Urionagüena Onaindia I
AU  - Plaza-Aulestia N
AU  - Medina Malone M
AU  - Gómez de Salazar JR
AU  - Corteguera M
AU  - Cebrián-Méndez L
AU  - Antón Pages FA
AU  - Lamua Riazuelo JR
AU  - Fábregas Canales MD
AU  - Alados Hernández MJ
AU  - Garijo Bufort M
AU  - Pàmies A
AU  - Sarabia de Ardanaz L
AU  - Aguirre-Del-Pino R
AU  - Cabezas Lefler JÁ
AU  - Seijas-Lopez Á
AU  - Carrasco Cubero MDC
AU  - López-Cerón Cofiño A
AU  - Ortiz-Santamaria V
AU  - Laiño Piñeiro M
AU  - Ordás Calvo C
AU  - Arconada Lopez C
AU  - Urruticoechea-Arana A
AU  - Garcia Magallon B
AU  - Acosta Alfaro AV
AU  - Leal Rodriguez S
AU  - Salido Olivares M
AU  - Lavilla Villar P
AU  - Brandy-García AM
AU  - Ros Vilamajo I
AU  - García Martos Á
AU  - Magallares Lopez BP
AU  - Sada Urmeneta G
AU  - Córdoba Martín C
AU  - Riera E
AU  - Bejerano C
AU  - Castañeda S
AU  - Blanco R
PY  - 2026
JO  - RMD open
DO  - 10.1136/rmdopen-2025-006549
UR  - https://doi.org/10.1136/rmdopen-2025-006549
ER  - 

APA

V, C., C, S., A, M., M, R., J, F., I, C., A, M., JJ, A. S., D, F., C, H., N, G. P., G, G. A., JR, M. S., A, G., M, I., F, L. M., Á, G. M., S, S., J, C., D, P. S., L, L., EC, C. P., P, C., C, A. L., L, S. I., E, L., C, P., I, U. O., N, P., M, M. M., JR, G. D. S., M, C., L, C., FA, A. P., JR, L. R., MD, F. C., MJ, A. H., M, G. B., A, P., L, S. D. A., R, A., JÁ, C. L., Á, S., MDC, C. C., A, L. C., V, O., M, L. P., C, O. C., C, A. L., A, U., B, G. M., AV, A. A., S, L. R., M, S. O., P, L. V., AM, B., I, R. V., Á, G. M., BP, M. L., G, S. U., C, C. M., E, R., C, B., S, C., & R, B. (2026). Anifrolumab in systemic lupus erythematosus: real-world evidence from a Spanish multicentre cohort of 206 patients and literature review.. RMD open. https://doi.org/10.1136/rmdopen-2025-006549

Source records